Cargando…

Incremental value of maximum voltage and activation-guided ablation for cavotricuspid isthmus-dependent atrial flutter

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. Radiofrequency (RF) catheter ablation is an effective method for treatment of typical cavo-tricuspid isthmus (CTI) dependent atrial flutter. However, despite the widespread use of contact force irrigated catheter, 11% of patients don’t achieve...

Descripción completa

Detalles Bibliográficos
Autores principales: Crocamo, A, Notarangelo, M F, Sciarroni, R, Vrenozaj, R, Dinatale, A, Bearzot, L, Gonzi, G, Fioravanti, M, Niccoli, G, Ardissino, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207348/
http://dx.doi.org/10.1093/europace/euad122.697
_version_ 1785046433535098880
author Crocamo, A
Notarangelo, M F
Sciarroni, R
Vrenozaj, R
Dinatale, A
Bearzot, L
Gonzi, G
Fioravanti, M
Niccoli, G
Ardissino, D
author_facet Crocamo, A
Notarangelo, M F
Sciarroni, R
Vrenozaj, R
Dinatale, A
Bearzot, L
Gonzi, G
Fioravanti, M
Niccoli, G
Ardissino, D
author_sort Crocamo, A
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. Radiofrequency (RF) catheter ablation is an effective method for treatment of typical cavo-tricuspid isthmus (CTI) dependent atrial flutter. However, despite the widespread use of contact force irrigated catheter, 11% of patients don’t achieve a first-pass CTI block, requiring additional RF applications or additional line during the same or a second procedure. From an anatomical point of view, CTI is composed of discrete bundles of muscle with intervening connective tissue, suggesting that its conduction proprieties are dependent of the anatomic architecture of the bundles. The maximum voltage-guided (MGV) ablation technique targets high-voltage electrograms along CTI to ablate the functionally active anatomic muscle bundle, without drawing a complete anatomic line. [1;2] PURPOSE: The aim of this study was to evaluate the efficacy of maximum voltage and activation-guided ablation (MVG/LAT) for CTI atrial flutter in real-world setting. METHODS: This was a prospective observational study in which all patients undergoing CTI atrial flutter ablation at the Electrophysiology Laboratory of our Department from 01/2021 to 10/2022 were recruited. Patients who were undergoing the ablation procedure after having already made an unsuccessful attempt of the same were excluded from the study. Substrate and activation mapping of CTI, both during flutter and during pacing from the proximal coronary sinus (CSp), was performed in all patients, identifying the earliest activated high-voltage channels, without the use of fluoroscopy, using the Smart-Touch SF catheter (CARTO 3, V7, Biosense Webster). High-voltage channels were validate also during lateral RA pacing. CTI ablation was performed only in channels with high voltage and early activation (W 45, AI 500). Bidirectional CTI block were validate by differential atrial pacing maneuvers and activation mapping during pacing from CSp. RESULTS: Procedural data of 39 patients were evaluated (mean age 68±13 years; men 92.6%; mean right atrium volume 149 mL). The mean number of points taken per map per patient was 1151. Bipolar thresholds were customized (0.5-2.5 mV) with the aim of better visualizing high-voltage channels. In 20/39(51.2%) patients ablation was performed during atrial flutter, in 19/39(48.8%) during pacing from proximal CS. In 19/39(48.8%) patients high-voltage channels were not detected at the central isthmus line (6 o'clock, LAO). The median number of RF applications to achieve bidirectional block of the CTI were 6 (1-20) in all patients (p=NS) (Figure 1,2). During a mean follow-up of 260 days (90-531) no recurrences were documented in any patient. CONCLUSIONS: MVG/LAT-guided ablation, targeting selectively conductive muscle fibers, decreases the number of RF applications and improves efficacy, mostly in patients with challenging anatomies. [Figure: see text] [Figure: see text]
format Online
Article
Text
id pubmed-10207348
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102073482023-05-25 Incremental value of maximum voltage and activation-guided ablation for cavotricuspid isthmus-dependent atrial flutter Crocamo, A Notarangelo, M F Sciarroni, R Vrenozaj, R Dinatale, A Bearzot, L Gonzi, G Fioravanti, M Niccoli, G Ardissino, D Europace 9.4.4 - Catheter Ablation of Arrhythmias FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. Radiofrequency (RF) catheter ablation is an effective method for treatment of typical cavo-tricuspid isthmus (CTI) dependent atrial flutter. However, despite the widespread use of contact force irrigated catheter, 11% of patients don’t achieve a first-pass CTI block, requiring additional RF applications or additional line during the same or a second procedure. From an anatomical point of view, CTI is composed of discrete bundles of muscle with intervening connective tissue, suggesting that its conduction proprieties are dependent of the anatomic architecture of the bundles. The maximum voltage-guided (MGV) ablation technique targets high-voltage electrograms along CTI to ablate the functionally active anatomic muscle bundle, without drawing a complete anatomic line. [1;2] PURPOSE: The aim of this study was to evaluate the efficacy of maximum voltage and activation-guided ablation (MVG/LAT) for CTI atrial flutter in real-world setting. METHODS: This was a prospective observational study in which all patients undergoing CTI atrial flutter ablation at the Electrophysiology Laboratory of our Department from 01/2021 to 10/2022 were recruited. Patients who were undergoing the ablation procedure after having already made an unsuccessful attempt of the same were excluded from the study. Substrate and activation mapping of CTI, both during flutter and during pacing from the proximal coronary sinus (CSp), was performed in all patients, identifying the earliest activated high-voltage channels, without the use of fluoroscopy, using the Smart-Touch SF catheter (CARTO 3, V7, Biosense Webster). High-voltage channels were validate also during lateral RA pacing. CTI ablation was performed only in channels with high voltage and early activation (W 45, AI 500). Bidirectional CTI block were validate by differential atrial pacing maneuvers and activation mapping during pacing from CSp. RESULTS: Procedural data of 39 patients were evaluated (mean age 68±13 years; men 92.6%; mean right atrium volume 149 mL). The mean number of points taken per map per patient was 1151. Bipolar thresholds were customized (0.5-2.5 mV) with the aim of better visualizing high-voltage channels. In 20/39(51.2%) patients ablation was performed during atrial flutter, in 19/39(48.8%) during pacing from proximal CS. In 19/39(48.8%) patients high-voltage channels were not detected at the central isthmus line (6 o'clock, LAO). The median number of RF applications to achieve bidirectional block of the CTI were 6 (1-20) in all patients (p=NS) (Figure 1,2). During a mean follow-up of 260 days (90-531) no recurrences were documented in any patient. CONCLUSIONS: MVG/LAT-guided ablation, targeting selectively conductive muscle fibers, decreases the number of RF applications and improves efficacy, mostly in patients with challenging anatomies. [Figure: see text] [Figure: see text] Oxford University Press 2023-05-24 /pmc/articles/PMC10207348/ http://dx.doi.org/10.1093/europace/euad122.697 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 9.4.4 - Catheter Ablation of Arrhythmias
Crocamo, A
Notarangelo, M F
Sciarroni, R
Vrenozaj, R
Dinatale, A
Bearzot, L
Gonzi, G
Fioravanti, M
Niccoli, G
Ardissino, D
Incremental value of maximum voltage and activation-guided ablation for cavotricuspid isthmus-dependent atrial flutter
title Incremental value of maximum voltage and activation-guided ablation for cavotricuspid isthmus-dependent atrial flutter
title_full Incremental value of maximum voltage and activation-guided ablation for cavotricuspid isthmus-dependent atrial flutter
title_fullStr Incremental value of maximum voltage and activation-guided ablation for cavotricuspid isthmus-dependent atrial flutter
title_full_unstemmed Incremental value of maximum voltage and activation-guided ablation for cavotricuspid isthmus-dependent atrial flutter
title_short Incremental value of maximum voltage and activation-guided ablation for cavotricuspid isthmus-dependent atrial flutter
title_sort incremental value of maximum voltage and activation-guided ablation for cavotricuspid isthmus-dependent atrial flutter
topic 9.4.4 - Catheter Ablation of Arrhythmias
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207348/
http://dx.doi.org/10.1093/europace/euad122.697
work_keys_str_mv AT crocamoa incrementalvalueofmaximumvoltageandactivationguidedablationforcavotricuspidisthmusdependentatrialflutter
AT notarangelomf incrementalvalueofmaximumvoltageandactivationguidedablationforcavotricuspidisthmusdependentatrialflutter
AT sciarronir incrementalvalueofmaximumvoltageandactivationguidedablationforcavotricuspidisthmusdependentatrialflutter
AT vrenozajr incrementalvalueofmaximumvoltageandactivationguidedablationforcavotricuspidisthmusdependentatrialflutter
AT dinatalea incrementalvalueofmaximumvoltageandactivationguidedablationforcavotricuspidisthmusdependentatrialflutter
AT bearzotl incrementalvalueofmaximumvoltageandactivationguidedablationforcavotricuspidisthmusdependentatrialflutter
AT gonzig incrementalvalueofmaximumvoltageandactivationguidedablationforcavotricuspidisthmusdependentatrialflutter
AT fioravantim incrementalvalueofmaximumvoltageandactivationguidedablationforcavotricuspidisthmusdependentatrialflutter
AT niccolig incrementalvalueofmaximumvoltageandactivationguidedablationforcavotricuspidisthmusdependentatrialflutter
AT ardissinod incrementalvalueofmaximumvoltageandactivationguidedablationforcavotricuspidisthmusdependentatrialflutter